Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 02-Apr-24 5:28 PM View:  | Bassler Bonnie L Director | Royalty Pharma Plc (RPRX) | 28-Mar-24 | Grant | 1,240 | $30.23 | $37,483.10 | 3% 46.52K to 47.76K | |
| 02-Apr-24 5:30 PM View: | Fernandez Henry A Director | Royalty Pharma Plc (RPRX) | 28-Mar-24 | Grant | 1,240 | $30.23 | $37,483.10 | 1% 98.93K to 100.17K | |
| 22-Feb-24 7:23 PM View: | Riggs Rory B Director | Royalty Pharma Plc (RPRX) | 20-Feb-24 | Conversion | 300,000 | -- | -- | 249% 120.29K to 420.29K | |
| 04-Jan-24 5:16 PM View: | Riggs Rory B Director | Royalty Pharma Plc (RPRX) | 04-Jan-24 | Sale | 35,702 | $27.55 | $983,504.00 | (23%) 155.99K to 120.29K | |
| 04-Jan-24 5:16 PM View: | Riggs Rory B Director | Royalty Pharma Plc (RPRX) | 03-Jan-24 | Sale | 199,098 | $27.79 | $5,532,280.00 | (56%) 355.09K to 155.99K | |
| 04-Jan-24 5:16 PM View: | Riggs Rory B Director | Royalty Pharma Plc (RPRX) | 02-Jan-24 | Sale | 235,200 | $28.52 | $6,707,080.00 | (40%) 590.29K to 355.09K | |
| 03-Jan-24 4:31 PM View: | Avara Management Ltd 10% Owner | Royalty Pharma Plc (RPRX) | 29-Dec-23 | Sale | 65,803 | $28.04 | $1,845,410.00 | (< 1%) 32.62M to 32.56M | |
| 29-Dec-23 5:14 PM View: | Fernandez Henry A Director | Royalty Pharma Plc (RPRX) | 29-Dec-23 | Grant | 1,353 | $27.71 | $37,493.00 | 1% 97.58K to 98.93K | |
| 29-Dec-23 5:11 PM View: | Bassler Bonnie L Director | Royalty Pharma Plc (RPRX) | 29-Dec-23 | Grant | 1,353 | $27.71 | $37,493.00 | 3% 45.17K to 46.52K | |
| 29-Dec-23 4:29 PM View: | Avara Management Ltd 10% Owner | Royalty Pharma Plc (RPRX) | 28-Dec-23 | Sale | 209,863 | $28.20 | $5,918,930.00 | (< 1%) 32.83M to 32.62M | |
| 29-Dec-23 4:29 PM View: | Avara Management Ltd 10% Owner | Royalty Pharma Plc (RPRX) | 27-Dec-23 | Sale | 41,729 | $28.01 | $1,168,750.00 | (< 1%) 32.87M to 32.83M | |
| 19-Dec-23 4:30 PM View: | Avara Management Ltd 10% Owner | Royalty Pharma Plc (RPRX) | 15-Dec-23 | Sale | 10,229 | $28.01 | $286,499.00 | (< 1%) 32.88M to 32.87M | |
| 15-Dec-23 4:31 PM View: | Avara Management Ltd 10% Owner | Royalty Pharma Plc (RPRX) | 14-Dec-23 | Sale | 364,441 | $28.91 | $10,534,300.00 | (1%) 33.25M to 32.88M | |
| 15-Dec-23 4:31 PM View: | Avara Management Ltd 10% Owner | Royalty Pharma Plc (RPRX) | 13-Dec-23 | Sale | 307,935 | $28.95 | $8,916,010.00 | (< 1%) 33.56M to 33.25M | |
| 16-Nov-23 5:50 PM View: | Legorreta Pablo G. CEO, Chairman of the Board Director 10% Owner | Royalty Pharma Plc (RPRX) | 16-Nov-23 | Disposition (other) | 383,000 | -- | -- | (9%) 4.04M to 3.66M | |
| 14-Nov-23 10:00 PM View: | Riggs Rory B Director | Royalty Pharma Plc (RPRX) | 13-Nov-23 | Conversion | 475,590 | -- | -- | 415% 114.7K to 590.29K | |
| 14-Nov-23 7:35 PM View: | Lloyd George W. EVP, Investments & CLO | Royalty Pharma Plc (RPRX) | 13-Nov-23 | Conversion | 150,000 | -- | -- | 16% 926.83K to 1.08M | |
| 03-Oct-23 4:25 PM View: | Fernandez Henry A Director | Royalty Pharma Plc (RPRX) | 29-Sep-23 | Grant | 1,384 | $27.08 | $37,475.30 | 1% 96.19K to 97.58K | |
| 03-Oct-23 4:23 PM View: | Bassler Bonnie L Director | Royalty Pharma Plc (RPRX) | 29-Sep-23 | Grant | 1,384 | $27.08 | $37,475.30 | 3% 43.78K to 45.17K | |
| 11-Aug-23 5:00 PM View: | Coyne Terrance P. EVP & CFO | Royalty Pharma Plc (RPRX) | 10-Aug-23 | Sale | 37,500 | $30.75 | $1,153,090.00 | (4%) 877.89K to 840.39K | |
| 11-Aug-23 5:00 PM View: | Coyne Terrance P. EVP & CFO | Royalty Pharma Plc (RPRX) | 09-Aug-23 | Sale | 37,500 | $30.72 | $1,151,940.00 | (4%) 915.39K to 877.89K | |
| 14-Jul-23 6:09 PM View: | Coyne Terrance P. EVP & CFO | Royalty Pharma Plc (RPRX) | 13-Jul-23 | Sale | 37,500 | $30.93 | $1,159,960.00 | (4%) 952.89K to 915.39K | |
| 14-Jul-23 6:09 PM View: | Coyne Terrance P. EVP & CFO | Royalty Pharma Plc (RPRX) | 12-Jul-23 | Sale | 37,500 | $31.07 | $1,165,260.00 | (4%) 990.39K to 952.89K | |
| 30-Jun-23 9:12 AM View: | Bassler Bonnie L Director | Royalty Pharma Plc (RPRX) | 30-Jun-23 | Grant | 1,208 | $31.03 | $37,481.00 | 3% 42.58K to 43.78K | |
| 30-Jun-23 9:15 AM View: | Fernandez Henry A Director | Royalty Pharma Plc (RPRX) | 30-Jun-23 | Grant | 1,208 | $31.03 | $37,481.00 | 1% 94.98K to 96.19K | |
| 28-Jun-23 4:01 PM View: | Legorreta Pablo G. CEO, Chairman of the Board Director 10% Owner | Royalty Pharma Plc (RPRX) | 28-Jun-23 | Purchase | 130,000 | $29.51 | $3,836,770.00 | 4% 3.62M to 3.75M | |
| 26-Jun-23 4:14 PM View: | Riggs Rory B Director | Royalty Pharma Plc (RPRX) | 23-Jun-23 | Grant | 7,747 | -- | -- | 7% 106.95K to 114.7K | |
| 26-Jun-23 4:09 PM View: | Hodgson David C Director | Royalty Pharma Plc (RPRX) | 23-Jun-23 | Grant | 7,747 | -- | -- | 89% 8.67K to 16.42K | |
| 26-Jun-23 4:04 PM View: | Desouza Errol B Director | Royalty Pharma Plc (RPRX) | 23-Jun-23 | Grant | 7,747 | -- | -- | 14% 56.7K to 64.44K | |
| 27-Jun-23 4:30 PM View: | Giuliani Mario Germano Director 10% Owner | Royalty Pharma Plc (RPRX) | 23-Jun-23 | Grant | 7,747 | -- | -- | < 1% 33.55M to 33.56M | |
| 26-Jun-23 4:11 PM View: | Love Ted W Director | Royalty Pharma Plc (RPRX) | 23-Jun-23 | Grant | 7,747 | -- | -- | 27% 29.19K to 36.94K | |
| 26-Jun-23 4:07 PM View: | Fernandez Henry A Director | Royalty Pharma Plc (RPRX) | 23-Jun-23 | Grant | 7,747 | -- | -- | 9% 87.24K to 94.98K | |
| 26-Jun-23 4:02 PM View: | Bassler Bonnie L Director | Royalty Pharma Plc (RPRX) | 23-Jun-23 | Grant | 7,747 | -- | -- | 22% 34.83K to 42.58K | |
| 26-Jun-23 4:12 PM View: | Norden Gregory Director | Royalty Pharma Plc (RPRX) | 23-Jun-23 | Grant | 7,747 | -- | -- | 14% 56.7K to 64.44K | |
| 26-Jun-23 4:05 PM View: | Engelbert Catherine M. Director | Royalty Pharma Plc (RPRX) | 23-Jun-23 | Grant | 7,747 | -- | -- | 30% 25.46K to 33.21K | |
| 13-Jun-23 4:01 PM View: | Legorreta Pablo G. CEO, Chairman of the Board Director 10% Owner | Royalty Pharma Plc (RPRX) | 13-Jun-23 | Purchase | 45,000 | $32.78 | $1,474,900.00 | 1% 3.57M to 3.62M | |
| 13-Jun-23 4:01 PM View: | Legorreta Pablo G. CEO, Chairman of the Board Director 10% Owner | Royalty Pharma Plc (RPRX) | 12-Jun-23 | Purchase | 45,000 | $33.00 | $1,484,950.00 | 1% 3.53M to 3.57M | |
| 06-Jun-23 10:00 PM View: | Lloyd George W. EVP, Investments & CLO | Royalty Pharma Plc (RPRX) | 06-Jun-23 | Sale | 79,099 | $33.82 | $2,674,800.00 | (8%) 1.01M to 926.83K | |
| 06-Jun-23 10:00 PM View: | Lloyd George W. EVP, Investments & CLO | Royalty Pharma Plc (RPRX) | 05-Jun-23 | Sale | 19,215 | $33.54 | $644,446.00 | (2%) 1.03M to 1.01M | |
| 06-Jun-23 10:00 PM View: | Lloyd George W. EVP, Investments & CLO | Royalty Pharma Plc (RPRX) | 02-Jun-23 | Sale | 93,907 | $33.64 | $3,159,350.00 | (8%) 1.12M to 1.03M | |
| 24-May-23 6:45 PM View: | Legorreta Pablo G. CEO, Chairman of the Board Director 10% Owner | Royalty Pharma Plc (RPRX) | 24-May-23 | Purchase | 150,000 | $32.25 | $4,837,440.00 | 4% 3.38M to 3.53M | |
| 22-May-23 8:36 PM View: | Riggs Rory B Director | Royalty Pharma Plc (RPRX) | 22-May-23 | Sale | 1,750,000 | $32.82 | $57,435,000.00 | (94%) 1.86M to 106.95K | |
| 17-May-23 6:41 PM View: | Legorreta Pablo G. CEO, Chairman of the Board Director 10% Owner | Royalty Pharma Plc (RPRX) | 17-May-23 | Purchase | 69,612 | $32.94 | $2,293,100.00 | 2% 3.31M to 3.38M | |
| 17-May-23 6:41 PM View: | Legorreta Pablo G. CEO, Chairman of the Board Director 10% Owner | Royalty Pharma Plc (RPRX) | 16-May-23 | Purchase | 160,388 | $33.57 | $5,383,730.00 | 5% 3.15M to 3.31M | |
| 12-May-23 6:43 PM View: | Riggs Rory B Director | Royalty Pharma Plc (RPRX) | 09-May-23 | Conversion | 300,000 | -- | -- | 19% 1.56M to 1.86M | |
| 31-Mar-23 4:40 PM View: | Fernandez Henry A Director | Royalty Pharma Plc (RPRX) | 31-Mar-23 | Grant | 1,049 | $35.73 | $37,478.30 | 1% 86.19K to 87.24K | |
| 31-Mar-23 4:38 PM View: | Bassler Bonnie L Director | Royalty Pharma Plc (RPRX) | 31-Mar-23 | Grant | 1,049 | $35.73 | $37,478.30 | 3% 33.78K to 34.83K | |
| 30-Mar-23 5:53 PM View: | Riggs Rory B Director | Royalty Pharma Plc (RPRX) | 30-Mar-23 | Sale | 130,024 | $36.26 | $4,714,340.00 | (8%) 1.69M to 1.56M | |
| 30-Mar-23 5:53 PM View: | Riggs Rory B Director | Royalty Pharma Plc (RPRX) | 29-Mar-23 | Sale | 9,926 | $36.95 | $366,766.00 | (< 1%) 1.7M to 1.69M | |
| 30-Mar-23 5:52 PM View: | Lloyd George W. EVP, Investments & CLO | Royalty Pharma Plc (RPRX) | 29-Mar-23 | Sale | 12,779 | $37.03 | $473,165.00 | (1%) 1.13M to 1.12M |
